Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.85 USD | -2.86% | +8.28% | -3.64% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Evolution of the average Target Price on INmune Bio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering INmune Bio, Inc.
Baird | |
B. Riley | |
BTIG |
EPS Revisions
- Stock Market
- Equities
- INMB Stock
- Consensus INmune Bio, Inc.